Related Experiment Video
Updated: Nov 5, 2025

06:40
Biofunctionalization of Magnetic Nanomaterials
Published on: July 16, 2020
2.8K
Functional bionanomaterials for cell surface engineering in cancer immunotherapy
APL Bioengineering
|May 13, 2021
Summary
Cell surface engineering (CSE) uses functional bionanomaterials to enhance cancer immunotherapy by improving interactions between immune effector cells and tumor cells for better anticancer immunity.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Immunology
Background:
- The cell surface is critical for immune recognition and privilege in cancer.
- Cell surface engineering (CSE) offers a promising strategy to enhance cancer immunotherapy.
- Functional bionanomaterials are increasingly utilized for CSE applications.
Purpose of the Study:
- To review recent advancements in using functional bionanomaterials for cell surface engineering (CSE) in cancer immunotherapy.
- To highlight the role of CSE in modulating immune effector cell (IEC) and tumor cell interactions.
- To discuss the potential of CSE for developing novel cancer immunity paradigms.
Main Methods:
- Application of functional bionanomaterials for cell surface modification.
- Techniques include genetic engineering, metabolic labeling, chemical conjugation, and hydrophobic insertion.
- CSE can be performed ex vivo or in vivo, on immune effector cells or tumor cells.
Main Results:
- Engineered cell surfaces facilitate enhanced recognition and interaction between IECs and tumor cells.
- CSE strategies lead to improved anticancer immunity.
- Development of new paradigms in cancer immunity through surface manipulation.
Conclusions:
- Functional bionanomaterials are key to advancing cell surface engineering for cancer immunotherapy.
- CSE holds significant potential for eliciting effective and targeted anticancer immune responses.
- Further research in bionanomaterial-based CSE can lead to innovative cancer treatment strategies.
More Related Videos
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
6.1K
10:16Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation
Published on: October 12, 2018
8.2K
Related Concept Videos
Tumor Immunotherapy
801
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
801
Targeted Cancer Therapies
8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.0K